Trials / Conditions / Tranquilizing Agents
Tranquilizing Agents
4 registered clinical trials studyying Tranquilizing Agents — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Nebulized Ketamine for the Treatment of Major Depressive Disorder in an Inpatient Setting NCT06752759 | Theresa Jacob, PhD, MPH | Phase 3 |
| Completed | Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder NCT05321602 | Luye Pharma Group Ltd. | Phase 1 |
| Completed | Relative Bioavailability of LY03010 Compared to Listed Drug NCT04922593 | Luye Pharma Group Ltd. | Phase 1 |
| Completed | A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR) NCT00294008 | Janssen Korea, Ltd., Korea | — |